Items of recent pandemic news: Auto-antibodies in long Covid; Moderna’s durability benefit over Pfizer; results from Johnson & Johnson’s two-dose trial; Pfizer’s effectiveness in kids 5-11; and who gets a Pfizer booster. Plus a frippery. FDA, CDC committee approve boosters … Continue reading →
Items of recent pandemic news: How to fix indoor air; Covid-sniffing dogs at Miami airport; an account of a “mild” breakthrough case of Covid-19; and today’s pivotal FDA meeting on boosters. Plus two fripperies. The booster debate comes to a … Continue reading →
Items of recent pandemic news: Visualizing the pandemic’s acceleration; the first DNA vaccine is authorized in India; the WHO extends its (mostly ignored) call for a moratorium on boosters; President Biden mandates vaccinations; and more. Plus a frippery. Biden’s vaccination … Continue reading →
Items of recent pandemic news: Vaccination halves chances of long Covid; the role of auto-antibodies in severe disease; rising out-of-pocket costs of Covid; the unlikelihood that September 20 will see booster shots; and more. Plus a frippery. 1. Boosters will … Continue reading →
Two senior FDA officials have resigned — “giants who helped bring us many safe and effective vaccines over decades of public service,” according to a former FDA scientist — reportedly in protest of political meddling in the work of the … Continue reading →
Items of recent pandemic news: Is the FDA moving too fast or too slow? Flying blind on delta breakthrough data; an early hint that boosters do what was hoped; and full FDA approval for Pfizer / BioNTech. Plus a frippery. … Continue reading →
Items of recent pandemic news: China will donate 2 billion doses; the unvaxxed consider shots more dangerous than Covid-19; FDA is fast-tracking full approval for Pfizer; countries and the WHO weigh booster shots; and more. Plus a frippery. 1. Pfizer … Continue reading →
As we predicted yesterday (and updated hours after publication), the CDC has revised its guidance from last May — which said that vaccinated people do not need to wear masks in most indoor settings. Now the recommendation is that everyone … Continue reading →
Items of recent pandemic news: Moderna applies to the FDA for full licensure; Minnesota and the Twin Cities end mask mandates; and cautious optimism that the pandemic is ending in the US. Plus news briefs and a brace of fripperies. … Continue reading →
Four items of recent pandemic news: Pfizer applies for full FDA approval; Moderna’s booster testing; the CDC’s optimistic report; and what it means that the US is open to waiving vaccine patent rights. Plus news briefs and a frippery. Waiving … Continue reading →
Three items of pandemic news you may have missed recently: Watching the virus evolve variants in a single human; a damning report on Emergent’s vaccine manufacturing plant; and the dimming prospects for herd immunity. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Covid-19 can damage the brain without infecting it; what’s up with the blood clots; and the FDA shuts down Emergent’s Baltimore operation. Plus news briefs and a frippery. FDA … Continue reading →
Three items of pandemic news you may have missed recently: Post-vaccination breakthrough infections are less than 0.008%; researchers estimate how much virus an infection produces; and an advisory committee punts on J&J. Plus news briefs and a frippery. Advisory committee … Continue reading →
Three items of pandemic news you may have missed recently: A study on transmission from the vaccinated; the South African variant can evade Pfizer; and the US government suggests pausing J&J vaccination. Plus news briefs and a frippery. FDA and … Continue reading →
Herewith three items of pandemic news you may have missed recently: Reinfection is more likely after age 65; the EU gives AstraZeneca’s vaccine a less than resounding go-ahead; and long Covid in children. Plus news briefs and a frippery. Long … Continue reading →
